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DNA derived from various human malignant and non-malignant tissues was hy- 
bridized with radioactive complementary R N A  (cR N A )  synthetized in vitro with the 
aid of Ecoli-RNA-polymerase by using DNA of human herpes group viruses as tem- 
plates. Epstein-Barr virus (EB  V )  -specific c R NA annealed significantly with DNA 
from nasopharyngeal carcinoma biopsies as well as with DNA preparations from 
leukocytes, bone marrow, lymph node and spleen of some patients with infectious mono- 
nucleosis. No significant hybridization was observed with either herpes simplex type 2 
or type I cRNA and DNA from ten cervical carcinoma biopsies. cRNA of human 
cytomegalovirus and varicellazoster virus did not hybridize with DNA from Kaposi’s 
sarcoma or DNA from heavily infiltrated spleens of patients with Hodgkin’s disease. 
These data do not exclude a role of these herpes viruses in the etiology of cervical 
carcinoma, Kaposi’s sarcoma and Hodgkin’s disease. They show, however, that such a 
relationship (if it exists) must differ quantitatively to a considerable extent from the 
one observed with EBV in EBV-associated tumors. 
During the past 10 years the oncogenic poten- 
tial of some members of the herpes virus group 
has been clearly established. A herpes virus was 
shown to be responsible for a lymphomatosis in 
chickens, Marek’s disease (Churchill and Biggs, 
1967; Biggs ef al., 1968); adenocarcinomas of 
the American leopard frog are most probably due 
to a herpes virus infection (Mizell et al., 1969); 
herpes virus saimiri and herpes virus ateles are 
highly oncogenic in certain species of New World 
primates (Melendez et al., 1969; Melendez et al., 
1972); a rabbit lymphoma virus has been isolated 
from cottontail rabbits (Hinze, 1969). In man 
there exists substantial evidence for a role of 
Epstein-Barr virus (EBV) in the induction of 
Burkitt’s lymphoma (reviewed by Epstein, 1970; 
Klein, 1972; zur Hausen 1972) and nasopharyn- 
geal carcinoma (Wolf et al., 1973). Another of the 
human herpes viruses, herpes simplex type 2, has 
frequently been observed in association with 
cervical carcinomas (Rawls et al., 1969; Nahmias 
et al., 1970). In vitro experiments revealed the 
transforming activity of EBV, partially inactivated 
herpes simplex types 1 and 2 (Duff and Rapp, 
1971), and a fourth human-pathogenic herpes 
virus, cytomegalovirus (Albrecht and Rapp, 
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1973). Whereas EBV transforms human lympho- 
cytes, the three latter apparently induce malignant 
transformation in primary hamster cells. 
The following experiments were devised in 
order to study further the role of herpes-group 
viruses in the induction of human malignancies. 
Complementary RNA (cRNA) was used as a 
probe for the presence of persisting viral DNA, 
since i t  represents a convenient tool for assessing 
the role of herpes viruses in human cancer 
(zur Hausen, 1972; zur Hausen and Schulte- 
Holthausen, 1972; zur Hausen et al., 1973). 
MATERIAL AND METHODS 
Cells 
P3HR-I cells were kept in medium RPMI 1640 
(GIBCO) supplemented with 10% calf serum. 
The Vero fine of African green monkey cells 
was maintained in MEM containing 10% calf 
serum. 
Primary human fibroblasts were obtained from 
human embryonic skin or lung cells, prepared in 
this laboratory. These cells were also kept in 
MEM supplemented with 10% calf serum. All 
tissue culture media contained 100 ,ug/ml strepto- 
mycin and 100 ,ug/ml penicillin G. 
Tumor materials 
Biopsy material from various tumors was 
frozen immediately after surgical removal and 
kept at -20°C until DNA extraction. Cellular 
DNA was extracted as described previously 
(zur Hausen et al., 1970). 
Viruses and viral purification 
Epstein-Barr Virus ( E B V ) .  EBV was con- 
centrated from the supernatant fluid of aged 
P3HR-1 cells as described before (Schulte- 
Holthausen and zur Hausen, 1970). The virus- 
producing cells were kept at 34" C during the 
whole incubation period. 
Herpes simplex virus. Herpes simplex viruses 
type 1 (Thea) and 2 (Haase) were kindly provided 
by Dr. Schneweis, Bonn, and grown on Vero 
cells. Vero cells were infected at an input multi- 
plicity of 2-3 and incubated for 24-48 h. Virus 
was isolated from the supernatant fluid as 
described before (Schulte-Holthausen and zur 
Hausen, 1970) or from infected cells. In the latter 
case cells were sedimented by low-speed centri- 
fugation, resuspended in 0.01 M Tris (PH 7.2) 
containing 0.5% NP40 and 8% sucrose as 
described by Weinberg and Becker (1969), 
incubated for 15 min at 37" C and again subjected 
to low-speed centrifugation. The resulting super- 
natant was layered on a sucrose gradient (20-35 %) 
and centrifuged at 30,000 x g  in the SW 27 rotor 
for 70 min at 4" C. The virus bands under these 
conditions in the lower third of the gradient. 
Cytomegalovirus. Human cytomegalovirus 
(AD-169) was grown on human skin or lung 
fibroblasts. Virus was transferred by cell-free 
infection after filtration of the supernatant 
through 1.2 Sartorius membrane filters (Sar- 
torius, Gottingen). The resulting preparation 
contained between lo4 and lo5 plaque-forming 
units per ml. For purification, the virus was 
harvested from cell-free supernatants of aged 
cultures approximately 7 days after infection. 
The purification conformed with the one re- 
ported for EBV (Schulte-Holthausen and zur 
Hausen, 1970). 
Varicella-Zoster virus. The stock virus was 
isolated from a patient who suffered simulta- 
neously from varicella and zoster eruptions. The 
virus was serologically identified as varicella- 
zoster virus and serially propagated on human 
embryonic lung or skin fibroblasts. Virus purifi- 
cation procedures were successful only from 
supernatants after long-term maintenance (12 
days) of the infected cells in the same medium. 
The concentration procedures were identical with 
the ones reported for EBV. 
Extraction of viral D N A  
Viral DNA was extracted from viral concen- 
trates as described previously (zur Hausen and 
Schulte-Holthausen, 1970). In brief, the virus 
was layered on top of preformed sucrose-SDS 
gradients, lysed by the addition of 1 mgfml of 
pronase B and 0.5% SDS and sedimented for 
14 h at 53,OoOxg in the SW 27 rotor at 25" C .  
The material banding at about 58 s was either 
pelleted in the 50 Ti rotor at 135,OOOxg for 15 h 
(20" C) or dialyzed. Thereafter it was adjusted 
with CsCl to a density of 1,710 g/cm and spun to 
equilibrium in the 50 Ti rotor for 72 h at 
60,000 xg. Fractions containing the viral DNA 
were pooled and dialyzed. 
Transcription of viral D N A  
Transcription of 1-2 ,ug of purified viral DNA 
was performed with E. coli RNA polymerase as 
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described in the preceding paper (zur Hausen 
et al., 1974). 
Hybridization methods 
The technology of nucleic acid hybridizations 
was essentially identical with the one described 
in the previous report (zur Hausen et a/., 1974). 
RESULTS 
Hybridizations with EB V-c R N A  
Fifty pg of DNA from biopsies of nasopharyn- 
geal carcinoma patients (obtained from Dr. G .  
Klein, Stockholm), from materials derived from 
patients with infectious mononucleosis, as well 
as DNA from other human tumors, together with 
control tissues, were subjected to hybridizations 
with EBV-specific cRNA. The result is shown in  
Figure 1. 
Most of the DNA from nasopharyngeal carci- 
noma biopsies annealed with EBV-cRNA sig- 
nificantly above the background of skin fibro- 
blast DNA. A substantial proportion hybridized 
above the level of Raji cell DNA which was shown 
in previous experiments to harbor approximately 
50 EBV genome equivalents per cell (zur Hausen 
et al., 1972). Three negative nasopharyngeal 
carcinomas were carefully re-examined histo- 
logically. Two of these biopsies did not contain 
any tumorous tissue, the third biopsy represented 
an adenocarcinoma. 
In infectious mononucleosis, DNA prepara- 
tions from the peripheral blood of four patients 
showed a different picture. Two of them, both 
from severe clinical cases, annealed with 1,800 
and 400 cpm, respectively. DNA from the bone 
marrow of the former also hybridized clearly with 
EBV-cRNA, although to a lesser extent than 
DNA prepared from the peripheral blood. DNA 
from the peripheral blood of two other patients 
with mild infectious mononucleosis was negative 
under the conditions of this test. In all four 
patients the diagnosis of IM was confirmed 
serologically (seroconversion of EBV-VCA anti- 
bodies). From a fifth patient with severe and long- 
lasting IM, DNA from spleen and lymph-node 
cells was obtained. Both preparations hybridized 
with EBV-cRNA (400 and 850 cpm, respectively). 
Thus three of five patients with IM revealed the 
presence of viral DNA in cells of either peripheral 
blood and bone marrow or of lymph nodes and 
spleens. All other material tested, in particular 
DNA from spleen cells of Hodgkin patients, 
DNA from Kaposi sarcomas and from human 
skin fibroblasts, showed no significant annealing 
with EBV-cRNA. 
Hybridizations with herpes simplex virus clz NA 
Purified HSV-1 (Thea) or HSV-2 (Haase)-DNA 
was transcribed in vitro and the resulting cRNA 
used for the detection of viral DNA sequences in 
human cervical carcinoma biopsies. Ten biopsies 
were carefully selected to represent in their 
majority tumor cells and annealed with type 1 
cpm hybr i -  
d i zed  * 10-2 
ZO 
13 
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FIGURE 1 
Hybridization of EBV-cRNA with DNA from 
human malignant and nonmalignant tissues. DNA 
from a non-virus-producing lyrnphoblastoid line Raji, 
which contains about 50 EBV genome equivalents 
per cell (zur Hausen et a/., 1972), served as positive 
control. The symbols in the column “infectious mono- 
nucleosis ” represent: I DNA from leukocytes of the 
peripheral blood, + DNA from a lymph node, DNA 
from cells of bone marrow, DNA from spleen cells. 
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and type 2 cRNA. DNA of HSV-1 or HSV-2- 
infected cells served as controls. The results are 
shown in Figures 2 and 3. 
Although approximately 20% of both cRNAs 
annealed to the respective positive control (and 
showed a clearly significant cross-hybridization 
with the DNA derived from cells infected with 
the heterologous virus), no annealing was evident 
with DNA from cervical carcinomas. Additional 
DNA preparations which originated from Kaposi 
sarcoma biopsies, from spleen cells of Hodgkin's 
disease patients, and from normal skin fibro- 
1 0  
cpm hybridized 
= 10-3 
ia 
cpm hybridi- 
z e d  a 10.3 
I 
FIGURE 2 
Hybridization of HSV-2-cRNA with DNA from 
cervical carcinoma biopsies and DNA from spleen 
cells of patients with Hodgkin's disease. DNA from 
HSV-2 and HSV-1-infected human cells served as 
positive control. 
FIGURE 3 
Hybridization of HSV-1-cRNA with DNA from 
cervical carcinoma biopsies and DNA from spleen 
cells of patients with Hodgkin's disease. DNA 
from HSV-1 and HSV-2-infected cells served as 
positive control. 
blasts, were all negative under the conditions 
tested. 
Hybridizations with varicella-zoster virus-c R N A  
Since there exist reports on serological cross- 
reactivity of HSV and VZ-antigens (Kapsenberg, 
1964; Ross et al., 1965; Schmidt et al., 1969) we 
investigated whether the reported serological 
results on HSV/cervical carcinoma interrelation- 
ship could be explained by the involvement of 
VZ virus in this disease. 
In addition, in view of the frequent occurrence 
of zoster eruptions in Hodgkin's disease patients, 
attention was focused on the question of whether 
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virus-specific DNA could be discovered in cells 
of heavily infiltrated spleens of such patients. 
VZ-cRNA, prepared from purified DNA of a 
laboratory strain of VZ virus, was used in these 
tests. The result is shown in Figure 4. 
Whereas the positive control annealed with 
12.5% of the input, no significant hybridization 
was observed with DNA from cervical carcinomas 
and from spleen cells of Hodgkin patients. A 
considerable number of other " control "material, 
i.e., DNA from condylomata acurninata, laryngeal 
papillomas, Kaposi's sarcomas and skin fibro- 
blasts, also reacted negatively. 
Hybridizations with CMV-cRNA 
In order to test the possible association of 
Kaposi's sarcoma with human cytomegalovirus 
I t  
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FIGURE 4 
Hybridization of varicella-zoster virus cRNA with 
DNA from various human tumors, spleen cells of 
patients with Hodgkin's disease, and normal human 
skin fibroblasts. DNA from varicella-infected human 
fibroblasts served as positive control. 
(Giraldo et al., 1972), DNA from those tumors 
was annealed with CMV-cRNA. The result is 
shown in Figure 5. DNA from CMV-infected 
human fibroblasts annealed with 28% of the 
input. Kaposi's sarcoma DNA (total tumor) 
however, was entirely negative in these hybridiza- 
tions. In addition, DNA from Hodgkin spleens 
and also DNA from human skin and human skin 
fibroblasts grown in tissue culture did not anneal 
with CMV-cRNA. 
DISCUSSlON 
Epstein-Barr virus DNA has been regularly 
observed in biopsies of Burkitt lymphomas (zur 
Hausen et al., 1970) and nasopharyngeal carci- 
nomas (zur Hausen et al., 1970; Nonoyama and 
Pagano, 1973). The presented results underline 
1 4  
c p m  hybri- 
d i z e d  x 10-3 
CMV - cRNA 
inDut 5011103 
FIGURE 5 
Hybridization of CMV-cRNA with DNA from 
Kaposi's sarcoma biopsies and spleen cells of Hodg- 
kin patients. CMV-infected human skin fibroblasts 
served as positive control. 
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the specific role of EBV in nasopharyngeal carci- 
noma. At the same time they demonstrate the 
presence of virus-specific DNA within cells of 
the peripheral blood, bone marrow, lymph nodes 
and spleen of some patients with infectious 
mononucleosis. It appears that some of these 
cells, as well as cells of those nasopharyngeal 
carcinomas which anneal in the higher range, 
must be loaded with virus-specific DNA. This 
conforms with previous findings of multiple viral 
genome equivalents in cells of Burkitt lymphomas, 
nasopharyngeal carcinomas (zur Hausen, 1972), 
and of non-virus-producing lymphoblastoid lines 
(zur Hausen and Schulte-Holthausen, 1970; 
Nonoyama and Pagano, 197 1 ; zur Hausen et al., 
1972). 
The sensitivity of hybridizations with EBV- 
cRNA permits the detection of two or three viral 
genome equivalents per cell, as determined by 
reconstruction tests (zur Hausen, 1972). Despite 
this limitation, the in vitro product represents a 
convenient tool in ascertaining the involvement 
of EBV in Burkitt’s lymphoma, nasopharyngeal 
carcinoma and infectious mononucleosis. 
If additional herpes group viruses play a role 
in certain human malignancies, we hoped to 
reveal their presence within those tumor cells by 
applying the same technique of cRNA-hybridiza- 
tions. The role of herpes simplex type 2 in cervical 
carcinoma and of cytomegalovirus in Kaposi’s 
sarcoma was of particular interest. Reconstruc- 
tion tests with cRNA of these human herpes 
viruses, synthetized in this laboratory, revealed 
that the sensitivity of the test slightly exceeded 
that of EBV-cRNA. It permitted the detection of 
approximately one genome equivalent per cell 
(zur Hausen et al., to be published). When using 
this material in DNA-cRNA hybridizations we 
failed to find DNA homologous to the respective 
viruses in those tested malignancies which are 
suspected of being associated with herpes virus 
infections. This accounts in particular for the 
cervical carcinoma biopsies which did not contain 
detectable amounts of either HSV-2 or HSV-1 
DNA. 
Obviously, these results do not exclude the 
presence of fragments of HSV-2 DNA within 
such tumors, as observed in one biopsy by Frenkel 
et al. (1972). Negative results, however, were 
obtained in similar experiments with HSV-2 
cRNA and DNA from approximately 30 addi- 
tional cervical cancer biopsies (Schulte-Holthau- 
sen, unpublished results; Petersen, personal 
communication). Cot-hybridizations with in vitro 
labelled HSV-2 DNA and DNA derived from 
five cervical carcinoma biopsies also failed to 
detect virus-specific DNA within the tumor cells 
(Pagano, personal communication). It is obvious, 
therefore, that the association of HSV-2 DNA 
with cervical carcinomas (if it exists) should be 
quantitatively vastly different as compared to 
EBV in EBV-associated tumors. 
The same accounts for a possible role of VZ 
and human CMV in Hodgkin’s disease and 
Kaposi’s sarcoma. Here in particular the role of 
CMV in Kaposi’s sarcoma deserves some 
discussion, since CMV has been isolated re- 
peatedly from this tumor (Giraldo et al., 1972). 
Preliminary results of Cot-hybridizations with in 
virro labelled CMV-DNA and Kaposi tumor 
DNA (which would have permitted the detection 
of about 0.2 genome per cell) were also negative 
(Dorries et al., unpublished results). Thus, mole- 
cular hybridization does not contribute further 
evidence for a role of CMV in this malignancy. 
Hybridizations with cRNA suffer from the 
disadvantage that the in vitro product may not be 
representative of the whole viral genome. Thus, 
if fragments of viral DNA, not transcribed in the 
in vitro reaction, were present in multiple copies, 
they would still escape detection by this method. 
Comparison of cRNA-annealing with Cot- 
hybridizations, however, by using in vitro labelled 
EBV-DNA, basically yielded identical results 
(Nonoyama and Pagano, 1973). In addition, the 
use of cRNA proved to be a convenient tool in 
the detection of EBV-specific sequences in 
Burkitt’s lymphoma and nasopharyngeal carci- 
noma biopsies, even by in-situ hybridizations 
(Wolf et al., 1973; Wolf et al., in preparation). 
By this same token, the annealing of cRNA of 
other human herpes group viruses with DNA 
from tumors suspected of being associated with 
such agents did not provide encouraging results. 
It should be emphasized, however, that these 
data do not exclude these viruses from the etio- 
logy of the respective tumors. 
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TENTATIVES DE DETECTION DE L’ADN SPECIFIQUE D U  VIRUS 
NUCLEIQUE AVEC L’ARN COMPLEMENTAIRE DES VIRUS 
HERPETIQUES HUMAINS 
L’ADN derive de divers tissus humains malins ou non a ttt? hybrid6 avec I’ARN coni- 
plkmentaire ( A R N c )  radioactif‘ synthetisi in vitro a I’aide de I’ARN polymerase 
d’E.coli, I’ADN des virus herphtiques hiimains servant d’indicateur. On observe une 
hybridation considhrable de I’A R Nc spkcifique du virus d’Epstein-Barr (EBV) avec 
I’AD N provenant de biopsies d’kpithklioma du rhino-pharynx r t  avec des preparations 
d’A D N provenant de leucocytes, de tnoelle ossruse, de ganglions lymphatiques et de 
rate de quelques sujets atteints de monanuclhose infectiectse. Aucune hybridation signi- 
ficative n’a Ptt observee avec 1’ARNc d’herpes simplex type 2 et I et I’ADN de dix 
biopsies de carcinonie cervical. On ne constate pas non plus d’hybridation de I’A R N c  de 
cytomhgalovirus humain et de virus de la varicelle et du zona avec I’ADN du sarconie 
de Kaposi ou I’ADN des rates fortement infiltrhes de sujets atteints de maladie de 
Hodgkin. Ces observations n’excluent pas la possibilitk d’un r61e de ces virus herpktiques 
dans I’ktiologie des carcinomes cervicaux, des sarcomes de Kaposi et de la maladie de 
Hodgkin. Toutefois, elles montrent que cette relation (si elle existe) doit &re sensi- 
blement diffkrente, au point de vue quantitatif, de celle que I’on observe avec I’EBV 
dans les tumeurs rrssocikes ir ce virus. 
DANS LES TUMEURS HUMAINES. Ir. HYBRIDATIONS DE L’ACIDE 
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